Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome. [electronic resource] by
- Xu, Feng
- Liu, Li
- Chang, Chun-Kang
- He, Qi
- Wu, Ling-Yun
- Zhang, Zheng
- Shi, Wen-Hui
- Guo, Juan
- Zhu, Yang
- Zhao, You-Shan
- Gu, Shu-Cheng
- Fei, Cheng-Ming
- Li, Xiao
Producer: 20161220
In:
Oncotarget vol. 7
Availability: No items available.
|
|
9.
|
Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome. [electronic resource] by
- Xu, Feng
- He, Qi
- Li, Xiao
- Chang, Chun-Kang
- Wu, Ling-Yun
- Zhang, Zheng
- Liu, Li
- Shi, Wen-Hui
- Zhu, Yang
- Zhao, You-Shan
- Gu, Shu-Cheng
- Fei, Cheng-Ming
- Guo, Juan
- Wu, Dong
- Zhou, Liyu
Producer: 20151009
In:
Scientific reports vol. 4
Availability: No items available.
|
|
10.
|
Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes. [electronic resource] by
- Xu, Feng
- Wu, Ling-Yun
- Chang, Chun-Kang
- He, Qi
- Zhang, Zheng
- Liu, Li
- Shi, Wen-Hui
- Guo, Juan
- Zhu, Yang
- Zhao, You-Shan
- Gu, Shu-Cheng
- Fei, Cheng-Ming
- Wu, Dong
- Zhou, Li-Yu
- Su, Ji-Ying
- Song, Lu-Xi
- Xiao, Chao
- Li, Xiao
Producer: 20160524
In:
Nature communications vol. 6
Availability: No items available.
|